Literature DB >> 2427217

Inert particles inhibit natural killer cell function in vitro.

W L Sibbitt, T Imir, A D Bankhurst.   

Abstract

Aqueous suspensions of inert particles were found to inhibit the baseline and interferon-enhanced natural killer (NK) cell activity of peripheral blood mononuclear cells (PBMC) and large granular lymphocytes (LGLs). This inhibition was induced with latex, silica, and Sephadex particles. The suppression of NK activity was not related to effector cell death as determined by trypan blue exclusion. The inhibition of NK cell function was more pronounced with prolonged incubation and could be partially reversed with monocyte depletion or the addition of indomethacin, a prostaglandin synthesis inhibitor, but not with the addition of the lipoxygenase inhibitors nordihydroguaiaretic acid and BW755C. Similarly, particle exposure inhibited the NK cell function of monocyte-depleted large granular lymphocytes with and without the add-back of glass adherent cells, implying that monocyte-independent NK suppressive mechanisms were also present. These data demonstrate that inert particles are immunosuppressive in vitro and can inhibit baseline and interferon-stimulated NK cell function of LGLs and PBMC through monocyte-dependent and independent pathways.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2427217     DOI: 10.1016/0008-8749(86)90384-9

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  2 in total

1.  Vaccinia virus recombinants expressing chimeric proteins of human immunodeficiency virus and gamma interferon are attenuated for nude mice.

Authors:  L D Giavedoni; L Jones; M B Gardner; H L Gibson; C T Ng; P J Barr; T Yilma
Journal:  Proc Natl Acad Sci U S A       Date:  1992-04-15       Impact factor: 11.205

2.  Neopterin as a new biomarker for the evaluation of occupational exposure to silica.

Authors:  Zeynep Zubeyde Altindag; Terken Baydar; Askin Isimer; Gonul Sahin
Journal:  Int Arch Occup Environ Health       Date:  2003-02-26       Impact factor: 3.015

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.